# GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
Canonical URL: https://biopharmsignal.com/news/GDRX/goodrx-earns-hitrust-i1-certification-for-the-second-consecutive-year-reinforcing-its-commitment-to-protecting-healthcare-data-at-scale
Ticker: GDRX
Company: GoodRx
Source: GoodRx
Published: 2026-02-02 14:00 EST
Original Source URL: https://investors.goodrx.com
## Summary

Independent assessment validates GoodRx’s continued leadership in cybersecurity and data protection SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its 2026 certification status

## Article Body
Independent assessment validates GoodRx’s continued leadership in cybersecurity and data protection SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its 2026 certification status
## Recent Company News
- 2026-05-27 13:00 EST — [GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs](https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs) — Source: GoodRx
- 2026-05-06 20:05 EST — [GoodRx Reports First Quarter 2026 Results](https://biopharmsignal.com/news/GDRX/goodrx-reports-first-quarter-2026-results) — Source: GoodRx
- 2026-05-01 12:10 EST — [GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients](https://biopharmsignal.com/news/GDRX/goodrx-expands-offerings-to-now-include-ozempicr-pill-for-type-2-diabetes-patients) — Source: GoodRx
- 2026-04-17 20:05 EST — [GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/GDRX/goodrx-announces-date-for-first-quarter-2026-earnings-release-and-conference-call) — Source: GoodRx
- 2026-04-15 13:00 EST — [GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price](https://biopharmsignal.com/news/GDRX/goodrx-now-offers-access-to-wegovyr-hd-at-399-per-month-self-pay-price) — Source: GoodRx
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)